Liang Howard
Insider CIK 1663427 · BGNE CFO & Chief Strategy Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BGNE BeiGene, Ltd. | S Sale | 2021-06-28 | 2021-06-30 | 446 | $365.00 | $162.8K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-18 | 2021-06-21 | 486 | $325.89 | $158.4K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-07 | 2021-06-09 | 650 | $354.16 | $230.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-01-15 | 2021-01-19 | 163,800 | — | $0 | 649,000 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-01-15 | 2021-01-19 | 12,600 | $6.50 | $81.9K | 12,600 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-15 | 2021-01-19 | 5,606 | $345.54 | $1.94M | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-15 | 2021-01-19 | 6,994 | $344.38 | $2.41M | 5,606 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-01-14 | 2021-01-19 | 18,200 | — | $0 | 812,800 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-14 | 2021-01-19 | 300 | $345.15 | $103.5K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-01-14 | 2021-01-19 | 1,400 | $6.50 | $9.1K | 1,400 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-14 | 2021-01-19 | 1,100 | $344.28 | $378.7K | 300 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-12-14 | 2020-12-16 | 2,600,000 | — | $0 | 831,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-14 | 2020-12-16 | 4,100 | $225.24 | $923.5K | 87,800 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-12-14 | 2020-12-16 | 91,900 | $6.50 | $597.4K | 91,900 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-14 | 2020-12-16 | 17,456 | $231.11 | $4.03M | 700 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-14 | 2020-12-16 | 24,842 | $230.51 | $5.73M | 18,156 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-14 | 2020-12-16 | 9,752 | $229.18 | $2.23M | 42,998 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-14 | 2020-12-16 | 5,885 | $228.23 | $1.34M | 52,750 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-14 | 2020-12-16 | 400 | $228.10 | $91.2K | 58,635 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-14 | 2020-12-16 | 7,500 | $227.72 | $1.71M | 59,035 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-14 | 2020-12-16 | 15,062 | $227.08 | $3.42M | 66,535 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-14 | 2020-12-16 | 6,203 | $226.40 | $1.40M | 81,597 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-12-14 | 2020-12-16 | 1,405,300 | $0.50 | $702.6K | 1,573,715 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-14 | 2020-12-16 | 700 | $232.19 | $162.5K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-10-05 | 2020-10-07 | 182,000 | — | $0 | 3,431,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 500 | $296.47 | $148.2K | 10,700 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 568 | $295.73 | $168.0K | 11,200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 1,415 | $294.92 | $417.3K | 11,768 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 817 | $293.26 | $239.6K | 13,183 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-10-05 | 2020-10-07 | 14,000 | $6.50 | $91.0K | 14,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 2,831 | $302.11 | $855.3K | 2,169 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 1,200 | $297.98 | $357.6K | 9,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 1,000 | $298.97 | $299.0K | 8,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 2,001 | $300.08 | $600.5K | 6,499 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 1,499 | $300.88 | $451.0K | 5,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 300 | $304.15 | $91.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-05 | 2020-10-07 | 1,869 | $303.24 | $566.8K | 300 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-09-14 | 2020-09-16 | 182,000 | — | $0 | 3,613,000 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-09-14 | 2020-09-16 | 14,000 | $6.50 | $91.0K | 14,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-14 | 2020-09-16 | 400 | $247.46 | $99.0K | 13,600 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-14 | 2020-09-16 | 1,681 | $248.93 | $418.5K | 11,919 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-14 | 2020-09-16 | 6,478 | $249.97 | $1.62M | 5,441 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-14 | 2020-09-16 | 3,157 | $250.71 | $791.5K | 2,284 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-14 | 2020-09-16 | 103 | $252.59 | $26.0K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-14 | 2020-09-16 | 2,181 | $251.95 | $549.5K | 103 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-29 | 2020-07-01 | 300 | $191.23 | $57.4K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2020-06-17 | 2020-06-19 | 315,341 | — | $0 | 315,341 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2020-06-17 | 2020-06-19 | 55,887 | — | $0 | 172,315 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-08 | 2020-06-10 | 453 | $170.84 | $77.4K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2019-11-18 | 2019-11-20 | 325,000 | — | $0 | 3,795,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 400 | $198.93 | $79.6K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2019-11-18 | 2019-11-20 | 25,000 | $6.50 | $162.5K | 25,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 1,156 | $191.80 | $221.7K | 23,844 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 2,311 | $192.63 | $445.2K | 21,533 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 6,944 | $193.60 | $1.34M | 14,589 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 8,156 | $194.62 | $1.59M | 6,433 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 5,633 | $195.57 | $1.10M | 800 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 200 | $196.63 | $39.3K | 600 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 200 | $197.55 | $39.5K | 400 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-06-27 | 2019-07-01 | 5,876 | $9.47 | $55.6K | 122,317 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2019-06-05 | 2019-06-07 | 558,285 | — | $0 | 558,285 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2019-06-05 | 2019-06-07 | 75,855 | — | $0 | 128,193 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2019-05-21 | 2019-05-22 | 301,600 | — | $0 | 4,120,000 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2019-05-21 | 2019-05-22 | 23,200 | $6.50 | $150.8K | 23,200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-05-21 | 2019-05-22 | 23,200 | $130.21 | $3.02M | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2019-05-06 | 2019-05-08 | 23,400 | — | $0 | 4,421,600 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2019-05-06 | 2019-05-08 | 1,800 | $6.50 | $11.7K | 1,800 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-05-06 | 2019-05-08 | 1,800 | $130.01 | $234.0K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2018-06-26 | 2018-06-28 | 364,208 | — | $0 | 364,208 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2018-06-26 | 2018-06-28 | 52,338 | — | $0 | 52,338 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2018-03-19 | 2018-03-20 | 313,664 | — | $0 | 4,445,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-19 | 2018-03-20 | 4,636 | $163.48 | $757.9K | 900 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-19 | 2018-03-20 | 5,133 | $162.79 | $835.6K | 5,536 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-19 | 2018-03-20 | 3,141 | $161.62 | $507.6K | 10,669 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-19 | 2018-03-20 | 9,618 | $160.60 | $1.54M | 13,810 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-19 | 2018-03-20 | 5,200 | $159.62 | $830.0K | 23,428 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-19 | 2018-03-20 | 500 | $158.45 | $79.2K | 28,628 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2018-03-19 | 2018-03-20 | 24,128 | $6.50 | $156.8K | 29,128 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-19 | 2018-03-20 | 900 | $164.36 | $147.9K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2018-03-16 | 2018-03-20 | 141,336 | — | $0 | 4,758,664 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-16 | 2018-03-20 | 400 | $157.98 | $63.2K | 5,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-16 | 2018-03-20 | 2,208 | $156.75 | $346.1K | 12,664 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-16 | 2018-03-20 | 1,000 | $154.95 | $154.9K | 14,872 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2018-03-16 | 2018-03-20 | 10,872 | $6.50 | $70.7K | 15,872 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2018-03-16 | 2018-03-20 | 7,264 | $157.41 | $1.14M | 5,400 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2017-06-29 | 2017-06-29 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2017-06-29 | 2017-06-29 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2016-11-16 | 2016-11-18 | 1,752,500 | — | $0 | 1,752,500 | SEC↗ |
| BGNE BeiGene, Ltd. | P Buy | 2016-02-08 | 2016-02-09 | 65,000 | $1.85 | $120.3K | 65,000 | SEC↗ |